0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Efficient induction of dopaminergic neuron differentiation from induced pluripotent stem cells reveals impaired mitophagy in PARK2 neurons.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Patient-specific induced pluripotent stem cells (iPSCs) show promise for use as tools for in vitro modeling of Parkinson's disease. We sought to improve the efficiency of dopaminergic (DA) neuron induction from iPSCs by the using surface markers expressed in DA progenitors to increase the significance of the phenotypic analysis. By sorting for a CD184high/CD44- fraction during neural differentiation, we obtained a population of cells that were enriched in DA neuron precursor cells and achieved higher differentiation efficiencies than those obtained through the same protocol without sorting. This high efficiency method of DA neuronal induction enabled reliable detection of reactive oxygen species (ROS) accumulation and vulnerable phenotypes in PARK2 iPSCs-derived DA neurons. We additionally established a quantitative system using the mt-mKeima reporter system to monitor mitophagy in which mitochondria fuse with lysosomes and, by combining this system with the method of DA neuronal induction described above, determined that mitophagy is impaired in PARK2 neurons. These findings suggest that the efficiency of DA neuron induction is important for the precise detection of cellular phenotypes in modeling Parkinson's disease.

          Related collections

          Author and article information

          Journal
          Biochem. Biophys. Res. Commun.
          Biochemical and biophysical research communications
          Elsevier BV
          1090-2104
          0006-291X
          January 29 2017
          : 483
          : 1
          Affiliations
          [1 ] Department of Physiology, Keio University, School of Medicine, Tokyo, Japan.
          [2 ] Center for Genomic and Regenerative Medicine, Juntendo University, School of Medicine, Tokyo, Japan. Electronic address: awado@juntendo.ac.jp.
          [3 ] Center for Genomic and Regenerative Medicine, Juntendo University, School of Medicine, Tokyo, Japan; Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan.
          [4 ] Department of Pharmacology, Hoshi University, Pharmacy and Pharmaceutical Sciences, Tokyo, Japan.
          [5 ] Laboratory for Cell Function Dynamics, Brain Science Institute, RIKEN, Saitama, Japan.
          [6 ] Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan.
          [7 ] Department of Physiology, Keio University, School of Medicine, Tokyo, Japan. Electronic address: hidokano@a2.keio.jp.
          Article
          S0006-291X(16)32262-8
          10.1016/j.bbrc.2016.12.188
          28057485
          6b69e447-dc31-453f-9c61-dc4062a9bea1
          History

          Dopaminergic neurons,Flow cytometry,Induced pluripotent stem cells,Mitophagy,Parkinson's disease

          Comments

          Comment on this article